Kushenol C exhibits anti-inflammatory and antioxidant activities; it inhibits BACE1 (IC50 = 5.45 µM), suppresses the production of inflammatory mediators (including NO, PGE2, IL-6, IL-1β, MCP-1, and IFN-β) in LPS-stimulated RAW264.7 macrophages in a dose-dependent manner; reduces phosphorylation of STAT1 and STAT6 in LPS-stimulated RAW264.7 cells; upregulates HO-1 expression and activity in LPS-stimulated RAW264.7 macrophages; protects HaCaT cells against DNA damage and cell death by enhancing endogenous antioxidant defenses (involving glutathione, superoxide dismutase, and catalase) and preventing reactive oxygen species production induced by tert-butyl hydroperoxide (tBHP); and inhibits BChE and AChE with IC50 values of 54.86 µM and 33.13 µM, respectively.